Company Filing History:

7 out of 9

Merial Sas

patents

2 out of 320

Merial Limited

patents

5 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2010

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7833783 - Postweaning multisystemic wasting syndrome and porcine circovirus from pigs (2010-11-16),

2. 7803926 - Postweaning multisystemic wasting syndrome and porcine circovirus from pigs (2010-09-28),

3. 7803613 - Postweaning multisystemic wasting syndrome and porcine circovirus from pigs (2010-09-28),

4. 7504206 - Postweaning multisystemic wasting syndrome and porcine circovirus from pigs (2009-03-17),

5. 7211379 - Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 (2007-05-01),

6. 7192594 - Postweaning multisystemic wasting syndrome and porcine circovirus from pigs (2007-03-20),

7. 7122192 - Porcine circoviruses, vaccines and diagnostic reagents (2006-10-17),

8. 6953581 - Porcine circovirus and parvovirus vaccine (2005-10-11),

9. 6660272 - Porcine circoviruses, vaccines and diagnostic reagents (2003-12-09),

10. 6517843 - Reduction of porcine circovirus-2 viral load with inactivated PCV-2 (2003-02-11),

11. 6391314 - Porcine circoviruses vaccines diagnostic reagents (2002-05-21),

12. 6368601 - Porcine circovirus vaccine and diagnostics reagents (2002-04-09),

13. 6217883 - Porcine circovirus and paravovirus vaccine (2001-04-17),

Title: Brian Martin Meehan: Innovator in Viral Genome Research

Introduction

Brian Martin Meehan is a notable inventor based in Belfast, GB. He has made significant contributions to the field of viral genome research, particularly in relation to porcine circovirus and postweaning multisystemic wasting syndrome. With a total of 13 patents to his name, Meehan's work has had a substantial impact on veterinary medicine and diagnostics.

Latest Patents

One of Meehan's latest patents focuses on the cloning of a novel PCVII viral genome. This patent describes the expression of proteins derived from the PCVII genome, which can be utilized in vaccine compositions for the prevention and treatment of PCVII infections. Additionally, these proteins are valuable in diagnostic methods for determining the presence of PCVII infections in vertebrate subjects. Polynucleotides derived from the viral genome can also serve as diagnostic primers and probes, enhancing the ability to detect these infections.

Career Highlights

Throughout his career, Meehan has worked with various organizations, including Merial Sas. His innovative research has led to advancements in the understanding and management of viral infections in pigs, contributing to improved animal health and welfare.

Collaborations

Meehan has collaborated with notable individuals in his field, including Gordon Moore Allan and John Ellis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Brian Martin Meehan's contributions to viral genome research and his impressive portfolio of patents underscore his role as a leading innovator in the field. His work continues to influence veterinary medicine and diagnostics, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.